New way to treat strokes is a 'game-changer,' docs say

April 10, 2012 By Patricia Anstett

A new generation of devices could significantly improve care for patients who have some of the most devastating types of strokes.

The Solitaire flow-restoration device, which gained last month, is used in the brains of much like an artery-opening angioplasty procedure for heart blockages.

Robert Lee Burns, 73, of Clay Township, Mich., credits it with saving his life.

"I thought it was over," said Burns. "Maybe there wasn't enough room upstairs for me yet."

A retiree who has worked on oil rigs and automotive assembly lines, Burns was one of the first five Michiganders to undergo the procedure. His surgery was Monday at St. John Hospital and Medical Center in Detroit.

St. John is the first hospital in southeast Michigan to use the device. The Detroit Medical Center and Henry Ford Health System, both based in Detroit; the Oakwood Healthcare System in Dearborn and Beaumont Hospitals, Royal Oak, are among those planning to add the technology soon.

"This is a very ," said Dr. Sandra Narayanan, a Detroit interventional neurologist. "I think it's going to be a game changer."

hope the new device proves to be more effective and easier to use than the first generation of products, which worked in a similar way, but weren't as good at removing clots.

Studies of the new device in Europe and Canada show that it significantly improved outcomes.

"We hope to replicate some of the results," said Dr. Andrew Xavier, director of interventional neurology at Oakwood.

Just a little more than a decade ago, doctors had few options for patients with the most devastating strokes that cause blockages in the brain. The addition of a drug called a (tPA) helped many people, but doctors say that as much as 40 percent to 50 percent of the time, the clot is too big to dissolve with the drug, which ideally is given within the first hour of stroke symptoms and no more than 4 { hours later.

Earlier devices also were technically demanding to use and proved a challenge for all but doctors in high-volume practices who performed the techniques often, said Dr. Richard Fessler, chief of surgery for the St. John Providence Health System .

The Solitaire device, made by Covidien of Dublin, Ireland, is minimally invasive. Doctors thread a thin tube through an artery - typically in the top of the leg - up to the brain. Then they advance within that tube another instrument with a miniature, Slinky-like stent to the blockage. The stent expands and helps doctors remove the clot more easily. To be sure the blockage is entirely removed, doctors take pictures of the arteries.

Burns, known to many in the Algonac area as Scrapper Bob because he salvages yards for scrap, was returning home in his truck Monday afternoon when he felt his right hand and leg go numb. He had not felt well that day, he recalled.

"I thought, 'My God, I'm having a stroke,'" Burns said.

He pulled over to get his phone out of his right pocket, but he was too weak to retrieve it. A man who saw him outside his home responded to his call for help.

A computer tomography scan at St. John River District Hospital in East China Township found that he had a blockage that was so big it was unlikely it would be helped by tPA, Fessler said. An ambulance brought Burns to River District's bigger sister hospital, St. John in Detroit.

Burns already is taking steps, has slight numbness but no major paralysis or other stroke complications and most likely will be able to go home soon. He should be able to get back to his life with a few weeks of physical therapy, Fessler said. "He's doing beautifully."

Explore further: New device performs better than old for removing blood clots

More information: Details about the recent approval of the device are on the web site of Covidien, the device manufacturer, at bit.ly/yqeRrX
See a video showing how the solitaire device works online at bit.ly/Hpbd3k

Related Stories

New device performs better than old for removing blood clots

February 3, 2012
An experimental blood clot-removing device outperformed the FDA-approved MERCI; retriever device, according to late-breaking science presented at the American Stroke Association's 2012 International Stroke Conference.

The Medical Minute: Pipes in the brain as treatment for aneurysms

December 9, 2011
Brain aneurysms are balloon-like out-pouchings that can develop off of brain arteries. Like balloons, these out-pouchings can burst causing a devastating type of stroke as blood leaks in and around the brain. Many years ago ...

Recommended for you

Could aggressive blood pressure treatments lead to kidney damage?

July 18, 2017
Aggressive combination treatments for high blood pressure that are intended to protect the kidneys may actually be damaging the organs, new research from the University of Virginia School of Medicine suggests.

Quantifying effectiveness of treatment for irregular heartbeat

July 17, 2017
In a small proof-of-concept study, researchers at Johns Hopkins report a complex mathematical method to measure electrical communications within the heart can successfully predict the effectiveness of catheter ablation, the ...

Concerns over side effects of statins stopping stroke survivors taking medication

July 17, 2017
Negative media coverage of the side effects associated with taking statins, and patients' own experiences of taking the drugs, are among the reasons cited by stroke survivors and their carers for stopping taking potentially ...

Study discovers anticoagulant drugs are being prescribed against safety advice

July 17, 2017
A study by researchers at the University of Birmingham has shown that GPs are prescribing anticoagulants to patients with an irregular heartbeat against official safety advice.

Protein may protect against heart attack

July 14, 2017
DDK3 could be used as a new therapy to stop the build-up of fatty material inside the arteries

Heart study finds faulty link between biomarkers and clinical outcomes

July 14, 2017
Surrogate endpoints (biomarkers), which are routinely used in clinical research to test new drugs, should not be trusted as the ultimate measure to approve new health interventions in cardiovascular medicine, according to ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.